Ceribell
Jane Chao, the co-founder and CEO of Ceribell, holds a Ph.D. in biophysics from Cornell University. Before she joined Ceribell, Jane had a solid history of leadership and success in business. She launched her career as a management consultant with McKinsey & Company, and later made her move into the medical space joining Novartis as their Senior Strategy Manager. She then enjoyed a successful career at Genentech as their Principal Manager of Portfolio Management Strategy.
In 2015, Jane started Ceribell full-time as the CEO, the position she currently holds. She has built and led the Ceribell team from early concept stages to a fully commercial, FDA-cleared, clinically proven and highly successful commercial product that is changing the standard of care for critically ill patients.
This person is not in any offices
Ceribell
1 followers
Ceribell is a fast growing venture-backed medical device start-up company founded by two faculty members at Stanford University. They have developed a highly innovative electroencephalography (EEG) device, which will make the diagnosis of neurological patients drastically more efficient.